androgen receptor inhibitor (University of Texas/Xi’an Jiaotong University/University of Adelaide)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameandrogen receptor inhibitor (University of Texas/Xi’an Jiaotong University/University of Adelaide)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesUniversity Of Texas System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXi'An Jiaotong UniversityUniversity Of Texas SystemUniversity Of Adelaide
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A